BRUTAL Hot Rebound Play which is massive underpriced here trading wayyy below cash
Market Cap $43 M / Cash $115 M or untill end 2021 / 2 Marketed Product / 1 Phase 3 trial (common warts) with results expected in Q4 2019 and many other phase 2 programs / because of their strategic change they wants to out-license all their Products which means HUGE upfront payments for the company (more infos below)= CHEAPEST Biotech you can get at this time
Aclaris Therapeutics (ACRS)
Market Cap: $43 M
Cash: $115 M or enough untill end 2021
Price $1.07
Aclaris Therapeutics Announces New Strategic Direction
investor.aclaristx.com
ACRS aquired a attractive drug from Allergan last year paid $65 m upfront alone for this drug which they now looking to outlicense .
globenewswire.com
Pipeline
aclaristx.com
Largest Shareholders:
Deerfield Management Company LP...5 893 416
Franklin Advisers, Inc....3 953 203
BlackRock Fund Advisors ...2 359 223
Broadfin Capital LLC...2 280 260
D. E. Shaw & Co. LP....2 049 462
Sofinnova Ventures, Inc.....1 911 573
Vivo Capital LLC ....1 647 214
Fidelity Management & Research Co...1 562 190
Polar Capital LLP...1 443 920
The Vanguard Group, Inc...1 142 022 |
